228 related articles for article (PubMed ID: 25220639)
1. Metabolomic analysis of simvastatin and fenofibrate intervention in high-lipid diet-induced hyperlipidemia rats.
Xu QY; Liu YH; Zhang Q; Ma B; Yang ZD; Liu L; Yao D; Cui GB; Sun JJ; Wu ZM
Acta Pharmacol Sin; 2014 Oct; 35(10):1265-73. PubMed ID: 25220639
[TBL] [Abstract][Full Text] [Related]
2. Application of GC/MS-based metabonomic profiling in studying the lipid-regulating effects of Ginkgo biloba extract on diet-induced hyperlipidemia in rats.
Zhang Q; Wang GJ; A JY; Wu D; Zhu LL; Ma B; Du Y
Acta Pharmacol Sin; 2009 Dec; 30(12):1674-87. PubMed ID: 19960012
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics study of the therapeutic mechanism of Schisandra Chinensis lignans in diet-induced hyperlipidemia mice.
Sun JH; Liu X; Cong LX; Li H; Zhang CY; Chen JG; Wang CM
Lipids Health Dis; 2017 Aug; 16(1):145. PubMed ID: 28764799
[TBL] [Abstract][Full Text] [Related]
4. Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome.
Vega GL; Ma PT; Cater NB; Filipchuk N; Meguro S; Garcia-Garcia AB; Grundy SM
Am J Cardiol; 2003 Apr; 91(8):956-60. PubMed ID: 12686335
[TBL] [Abstract][Full Text] [Related]
5. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
[TBL] [Abstract][Full Text] [Related]
6. UPLC/Q-TOF-MS/MS-based metabolomics revealed the lipid-lowering effect of Ilicis Rotundae Cortex on high-fat diet induced hyperlipidemia rats.
Yang B; Xuan S; Ruan Q; Jiang S; Cui H; Zhu L; Luo X; Jin J; Zhao Z
J Ethnopharmacol; 2020 Jun; 256():112784. PubMed ID: 32222573
[TBL] [Abstract][Full Text] [Related]
7. Feces and liver tissue metabonomics studies on the regulatory effect of aspirin eugenol eater in hyperlipidemic rats.
Ma N; Liu X; Kong X; Li S; Jiao Z; Qin Z; Dong P; Yang Y; Li J
Lipids Health Dis; 2017 Dec; 16(1):240. PubMed ID: 29228968
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia.
Milionis HJ; Papakostas J; Kakafika A; Chasiotis G; Seferiadis K; Elisaf MS
J Clin Pharmacol; 2003 Aug; 43(8):825-30. PubMed ID: 12953339
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia.
Ellen RL; McPherson R
Am J Cardiol; 1998 Feb; 81(4A):60B-65B. PubMed ID: 9526816
[TBL] [Abstract][Full Text] [Related]
10. LC-MS based urinary metabolomics study of the intervention effect of aloe-emodin on hyperlipidemia rats.
Ji H; Liu Y; He F; An R; Du Z
J Pharm Biomed Anal; 2018 Jul; 156():104-115. PubMed ID: 29698861
[TBL] [Abstract][Full Text] [Related]
11. Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia.
Adkins JC; Faulds D
Drugs; 1997 Oct; 54(4):615-33. PubMed ID: 9339964
[TBL] [Abstract][Full Text] [Related]
12. A plasma metabonomics study on the therapeutic effects of the Si-miao-yong-an decoction in hyperlipidemic rats.
Shi S; Liu Z; Xue Z; Chen X; Chu Y
J Ethnopharmacol; 2020 Jun; 256():112780. PubMed ID: 32222575
[TBL] [Abstract][Full Text] [Related]
13. UPLC-Q-TOF/MS-based urine and plasma metabonomics study on the ameliorative effects of aspirin eugenol ester in hyperlipidemia rats.
Ma N; Karam I; Liu XW; Kong XJ; Qin Z; Li SH; Jiao ZH; Dong PC; Yang YJ; Li JY
Toxicol Appl Pharmacol; 2017 Oct; 332():40-51. PubMed ID: 28733207
[TBL] [Abstract][Full Text] [Related]
14. ¹H-NMR and MS based metabolomics study of the intervention effect of curcumin on hyperlipidemia mice induced by high-fat diet.
Li ZY; Ding LL; Li JM; Xu BL; Yang L; Bi KS; Wang ZT
PLoS One; 2015; 10(3):e0120950. PubMed ID: 25786031
[TBL] [Abstract][Full Text] [Related]
15. [Intervention of Huayu Qutan Recipe on liver SREBP-2 signal pathway of hyperlipidemia rats of pi deficiency syndrome].
Leng X; Jia LQ; Yang GL; Wang JY; Zhu ML; Wang Y; Xu Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Mar; 35(3):320-6. PubMed ID: 25951638
[TBL] [Abstract][Full Text] [Related]
16. [Lipid-lowering effect and mechanism of Danhong Injection on hyperlipidemia rats based on lipid metabolism disorder].
DU HX; Zhou HF; He Y; Wan HT; Yang JH
Zhongguo Zhong Yao Za Zhi; 2020 Jul; 45(13):3203-3210. PubMed ID: 32726030
[TBL] [Abstract][Full Text] [Related]
17. NMR-based metabolomics highlights differences in plasma metabolites in pigs exhibiting diet-induced differences in adiposity.
Jégou M; Gondret F; Lalande-Martin J; Tea I; Baéza E; Louveau I
Eur J Nutr; 2016 Apr; 55(3):1189-99. PubMed ID: 25997692
[TBL] [Abstract][Full Text] [Related]
18. [Yacon root extract improves lipid metabolism in hyperlipidemic rats by inhibiting HMGCR expression and activating the PPAR
Gong S; Yang J; Zhang J; Wu X; Jiang S; Zhang Y; Gong G; Wu N; Sun J; Wu Z
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Nov; 43(11):1977-1983. PubMed ID: 38081618
[TBL] [Abstract][Full Text] [Related]
19. The Anti-hyperlipidemia Effects of Raw Polygonum multiflorum Extract in Vivo.
Xian Z; Liu Y; Xu W; Duan F; Guo Z; Xiao H
Biol Pharm Bull; 2017; 40(11):1839-1845. PubMed ID: 29093330
[TBL] [Abstract][Full Text] [Related]
20. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
